Report cover image

Companion Diagnostics (CDx) Markets: Global Trends, Opportunities, and Forecasts, 4th Edition

Publisher Kalorama Information
Published Oct 24, 2025
Length 140 Pages
SKU # KLI20494737

Description



The next era of healthcare is here—and it’s powered by companion diagnostics (CDx). These essential tools are redefining how diseases are detected, monitored, and treated by aligning diagnostics directly with therapeutic decision-making. Kalorama Information’s Companion Diagnostics (CDx) Markets: Global Trends, Opportunities, and Forecasts, 4th Edition provides an in-depth, data-driven analysis of this rapidly evolving market—one that sits at the intersection of diagnostics, pharmaceuticals, and precision medicine.

A New Standard for Precision Healthcare

As healthcare systems worldwide seek greater efficiency and cost control, companion diagnostics offer a critical solution. By identifying which patients are most likely to benefit from specific therapies—and which are not—these technologies reduce unnecessary treatments, improve patient outcomes, and optimize healthcare spending. This is especially vital as the cost of new oncology and specialty therapeutics continues to rise. The report examines how companion diagnostics are shaping personalized care across oncology and other medical specialties, supported by robust market data, forecast models, and expert insights.

Technology Driving Discovery and Commercialization

Breakthroughs in genomics, biomarker research, and diagnostic technologies are fueling an unprecedented expansion of CDx development. From genetic panels and drug metabolism tests to therapeutic drug monitoring, the report explores how novel biomarkers are transforming disease understanding and enabling a transition from a one-size-fits-all model to truly personalized medicine. These technologies are driving new partnerships between pharmaceutical and diagnostic developers and reshaping the clinical trial and commercialization landscape.

Comprehensive Market Analysis from 2024-2029

Built on Kalorama Information’s trusted methodologies, this fourth edition presents global market data based on supplier sales to end users, with 2024 as the base year and forecasts through 2029. The report provides insights incorporating revenue trends, demographic influences, biomarker and CDx deal activity, regulatory developments, and company performance analysis. Basic competitor summaries and growth projections (CAGRs, 2024–2029) are included to guide strategic decision-making.

An Essential Resource for Diagnostics and Pharma Stakeholders

Designed for executives, strategists, and innovators across diagnostics, biotechnology, and pharmaceutical sectors, this report offers actionable intelligence to:
  • Benchmark current market performance
  • Identify emerging opportunities in companion diagnostics development
  • Align R&D, regulatory, and commercialization strategies
  • Evaluate competitive positioning in a rapidly evolving marketplace
The Bridge Between Diagnostics and Therapeutics

As the healthcare industry continues to evolve under economic pressures, regulatory shifts, and scientific breakthroughs, companion diagnostics stand as the bridge to a more targeted, cost-effective, and patient-centered future.

Companion Diagnostics (CDx) Markets: Global Trends, Opportunities, and Forecasts, 4th Edition delivers the clarity, context, and strategic insight needed to navigate this transformation—and lead it.

Please Note: Single user allows for up to 3 users for this report.

Table of Contents

140 Pages
    • Overview
    • Key Findings
    • Definitions of Companion Diagnostics and Personalized Medicine Used in This Report
    • Scope and Methodology
    • Market Summary
    • Overview
    • Regulatory Changes
    • Reimbursement Breakthroughs and Challenges
    • Next Generation Sequencing Coverage
    • CDx Approvals: United States FDA
    • The Market for Targeted Therapies: Oncology
    • Development in NGS for CDx
    • Next-Generation Sequencing (NGS) or Massively Parallel Sequencing in Cancer Diagnostics
    • The Evolving Opportunity for Clinical Sequencing and CDx in Japan
    • Disease Profiles in CDx Markets
    • Cardiovascular Disease
    • Infectious Diseases
    • Market Overview
    • Biomarkers in Therapeutic Labeling
    • Companion Diagnostics in Oncology
    • Companion Diagnostics in Other Diseases
    • Cardiology and Hematology
    • Infectious Disease
    • Diagnostic Techniques
    • Market Overview
    • Regional Market Review
    • Introduction
    • Competitive Landscape
    • Company Profiles
    • Agilent Technologies/Dako
    • Guardant Health
    • Life Technologies (Thermo Fisher Scientific)
    • Qiagen
    • Roche

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us